Laurus Hiv Drugs
Slow improvement in sales could weigh on pharma firm Laurus' performance
Company reported lower-than-expected revenue after missing target in key segment
 "Slow improvement in sales could weigh on pharma firm Laurus' performance")
Updated On : 26 Jan 2024 | 10:12 PM IST
Laurus is ready to flood US with cheap HIV drugs
US patents on key components for some important HIV therapies are set to expire starting in December and Laurus Labs is gearing up to cash in
 "Laurus is ready to flood US with cheap HIV drugs")
Updated On : 05 Dec 2017 | 2:33 AM IST
